{
  "id": "5c65468ce842deac6700001e",
  "type": "factoid",
  "question": "Name one CCR4 targeted drug.",
  "ideal_answer": "Mogamulizumab is an anti-CCR4 monoclonal antibody.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/29414279"
  ],
  "snippets": [
    {
      "text": "Mogamulizumab (Anti-CCR4) in HTLV-1-Associated Myelopathy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29414279",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "We evaluated mogamulizumab, a humanized anti-CCR4 monoclonal antibody that targets infected cells, in patients with HAM-TSP.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29414279",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Mogamulizumab"
}